Democratic debate recap: Health insurance and drug prices get the spotlight
The last Democratic debate before the Iowa caucuses focused more on foreign policy than healthcare.
Drug Pricing
Appeals court considers HHS’ TV drug price disclosure rule
The appeals court questioned HHS’ authority and whether the list price would only confuse consumers.
Why the dance between manufacturers and PBMs continues
States have targeted co-pay accumulators, claiming they run up costs for patients who need expensive specialty drugs. Here’s why their legislation hasn’t yet had the intended impact.
Prices to increase on hundreds of drugs in 2020
Drug companies kicked off the new year by announcing price hikes.
Watch: Martin Sheen rants about drug prices in SingleCare ad
“That’s larceny!” Sheen exclaims upon seeing the cost of his medicine.
It’s time to push back on drug price legislation
Sander Flaum wants pharma to push back on pricing legislation.
GOP, Dems agree on international reference price policy, but the devil is in the details
International reference pricing for drugs is great in theory, but Dems and the GOP are at odds over the details in each plan.
Want to save money on drug prices? Don’t listen to Washington
Sander Flaum urges Americans to ignore politicians’ calls to head north of the border for their prescription medication.
AARP on its latest drug price campaign: ‘There’s a lot of anger out there’
The organization has fighting words for Big Pharma.
4 takeaways from the PBM drug-price hearing on Capitol Hill
PBM execs were grilled on transparency, rebates and mega-mergers during Tuesday’s Senate Finance Committee hearing.
